VamosVentures — 2022 Investments
8 investments dated 2022 · listed companies and verified rows first · show all
Brex provides financial services and software for companies, including corporate cards and expense management tools.
AI & Machine LearningEnterprise SoftwareFintechSaaSSan Francisco, US
Henrique Dubugras(Co-CEO)inPedro Franceschi(Co-founder & CEO)in
Co-investorsKleiner PerkinsY CombinatorDST GlobalRibbit CapitalTiger Global Management137 Ventures+30 more
Co-investorsAgFunderAngel Collective Opportunity FundArgonautic VenturesFifty YearsGermin8 VenturesHorizons Ventures+3 more
Culina Health connects patients with registered dietitians for personalized, virtual nutrition care that is in-network with major insurance plans.
Digital HealthHealthtechWellness & FitnessNew Jersey, US
Vanessa Rissetto(Co-founder)inTamar Samuels(Co-founder)in
Co-investorsCake VenturesGraham Walker VentureMGV.VCREDO VenturesRethink ImpactTensility Venture Partners+1 more
Finix provides embedded payments infrastructure for software platforms, acting as an outsourced PayFac (PayFac-as-a-Service) with end-to-end payments technology, compliance and risk management, merchant onboarding, and reporting tools.
Data & InfrastructureDeveloper ToolsEnterprise SoftwareFintechSaaSSan Francisco, US
Richie Serna(Founder)inSean Donovan(Founder)in
Co-investorsInsight PartnersInspired CapitalLightspeed Venture PartnersAcrew CapitalCap Table CoalitionCiti Ventures+13 more
Handspring provides virtual mental health therapy for children, teens, and young adults, with insurance coverage and rapid access to care without waitlists.
Digital HealthHealthtechMental Health
Sahil Choudhryin
Co-investors25MadisonCobalt VenturesCornucopian Capital ManagementNextView VenturesNVP CapitalRPS Ventures+3 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
CABRA SportsMigaZócalo Health
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.



























